Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hosmane

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Cancer Biotherapy & Radiopharmaceuticals|November 9, 2022
New Boron Delivery AgentsAnnette G Beck-Sickinger, Daniel P Becker, Oksana Chepurna, et al.
Elife|September 21, 2016
Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cellsErik C Hansen, Monica Ransom, Jay R Hesselberth, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 11, 2020
Boron-Containing Lipids and Liposomes: New Conjugates of Cholesterol with Polyhedral Boron HydridesVladimir I Bregadze, Igor B Sivaev, Ravindra Dhar Dubey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokineticsMichael A Carducci, Joel B Nelson, M Kathy Bowling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 StudyBenoit You, Vasudha Sehgal, Balakrishna Hosmane, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2018
Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and waneZheng Wang, Evelyn E Gurule, Timothy P Brennan, et al.
Cell Host & Microbe|December 16, 2016
The mTOR Complex Controls HIV LatencyEmilie Besnard, Shweta Hakre, Martin Kampmann, et al.
Immunity|October 19, 2017
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4<sup>+</sup> T Cells Permissive for Latent HIV-1 InfectionLiang Shan, Kai Deng, Hongbo Gao, et al.
The Lancet. Gastroenterology & Hepatology|August 9, 2020
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation studyStephen A Harrison, Vlad Ratziu, Jérôme Boursier, et al.
EMBO Molecular Medicine|March 31, 2015
Targeting DDX3 with a small molecule inhibitor for lung cancer therapyGuus M Bol, Farhad Vesuna, Min Xie, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Cancer Biotherapy & Radiopharmaceuticals|November 9, 2022
New Boron Delivery AgentsAnnette G Beck-Sickinger, Daniel P Becker, Oksana Chepurna, et al.
Elife|September 21, 2016
Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cellsErik C Hansen, Monica Ransom, Jay R Hesselberth, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 11, 2020
Boron-Containing Lipids and Liposomes: New Conjugates of Cholesterol with Polyhedral Boron HydridesVladimir I Bregadze, Igor B Sivaev, Ravindra Dhar Dubey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokineticsMichael A Carducci, Joel B Nelson, M Kathy Bowling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 StudyBenoit You, Vasudha Sehgal, Balakrishna Hosmane, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2018
Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and waneZheng Wang, Evelyn E Gurule, Timothy P Brennan, et al.
Cell Host & Microbe|December 16, 2016
The mTOR Complex Controls HIV LatencyEmilie Besnard, Shweta Hakre, Martin Kampmann, et al.
Immunity|October 19, 2017
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4<sup>+</sup> T Cells Permissive for Latent HIV-1 InfectionLiang Shan, Kai Deng, Hongbo Gao, et al.
The Lancet. Gastroenterology & Hepatology|August 9, 2020
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation studyStephen A Harrison, Vlad Ratziu, Jérôme Boursier, et al.
EMBO Molecular Medicine|March 31, 2015
Targeting DDX3 with a small molecule inhibitor for lung cancer therapyGuus M Bol, Farhad Vesuna, Min Xie, et al.
Pageof 19